Neustar highlights rise in ransom-related DDoS attacks and greater use of existing attack vectors
Neustar, Inc., a global information services and technology company and leader in identity resolution, has today published its report entitled ‘Cyber Threats and Trends: Pandemic Style’, detailing the security risks faced by companies as the COVID-19 pandemic accelerated the digital revolution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210128005015/en/
Figure 1: Percentage change in number of attacks by size category, 2020 vs. 2019 (Graphic: Business Wire)
Informed by data from Neustar’s Security Operations Center (SOC), the report reveals a 154 percent increase in the number of attacks between 2019 and 2020, with growth in ransom-related DDoS (RDDoS) attacks and a rise in use of existing attack vectors, including web applications. The report also provides key details around the amount, size, duration and intensity of DDoS attacks throughout 2020 to keep cyber security professionals informed.
DDoS ransom attacks on the rise
Primarily, the report highlights a rise in ransom-related DDoS attacks, by which extortion demands are issued against organisations. These attacks grew in persistence and sophistication, as well as by target, compared to previous years.
While RDDoS is not a new phenomenon for many online industries, attackers have recently set their sights on organisations across a wider variety of sectors including financial services, government and telecommunications.
One reason for the adoption of DDoS as a ransom vector, as opposed to using malware, is the ease with which such attacks can be carried out. Infecting an organisation’s networks with malware or ransomware takes time and careful planning. Launching a DDoS attack, in comparison, has become relatively simple and has the added benefit of being harder to trace back to its origin.
2020 saw bad actors posing as prolific threat groups such as Fancy Bear in ransom notes – capitalising on fear of high-profile nation-state attacks – and threatening DDoS attacks unless the ransom was paid within a specific time frame.
“Organisations should avoid paying these ransoms,” said Michael Kaczmarek, Vice President of Security Product Management at Neustar. “Instead, any attack should be reported to the nearest law enforcement field office, as the information may help identify the attackers and ultimately hold them accountable. Beyond this, organisations can prepare by setting up a robust DDoS mitigation strategy, including assessing the risks, evaluating available solutions, considering mitigation strategies and keeping their plan and provider up to date.”
Existing attack vectors
While 2020 did not see any dramatically new attack vectors emerge, there was certainly a greater use of existing ones like web applications, which were the top targeted hacking vector in 2020.
Numerous built-in access protocols, which have been increasingly exploited as attack vectors, came up again in 2020. In fact, the FBI issued an alert in July warning that common network protocols like ARMS (Apple Remote Management Services), WS-DD (Web Services Dynamic Discovery) and CoAP (Constrained Application Protocol) were being abused by hackers to conduct DDoS reflection and amplification attacks – while cautioning that disabling them could cause a loss in business productivity and connectivity.
In response to this heightened threat level, the results of the latest Neustar International Security Council (NISC) survey indicated that more cyber security professionals are outsourcing DDoS mitigation, having increased by a full percentage point in the last quarter alone.
In 2020, Neustar also saw an increase in attacks on the Domain Name System itself — or what look like attacks, as bad actors abuse the system.
“Acting as the Internet’s address book and backbone of today’s digital services, it’s unsurprising that DNS is an increasingly appealing target for malicious actors, particularly as more consumers turn to websites during peak online shopping periods,” said Rodney Joffe, Senior Vice President and Fellow, Neustar.
Recent NISC survey data supports this trend, with three in five respondents in a December 2020 study reporting they had fallen victim to a DNS attack in the last year. Even more concerning, over 70 percent of organisations admitted to having reservations about their awareness of, and ability to respond to, DNS attacks.
The total number of DDoS attacks Neustar mitigated on behalf of its customers in 2020 increased by more than two and a half times over 2019. The largest attack size observed during this time was also the largest that Neustar has ever mitigated and, at 1.17 Terabits per second (Tbps), among the largest ever seen on the Internet. The longest duration for a single attack was also the longest Neustar has mitigated, at 5 days and 18 hours.
A copy of the Neustar report is available here.
Neustar is an information services and technology company and a leader in identity resolution providing the data and technology that enables trusted connections between companies and people at the moments that matter most. Neustar offers industry-leading solutions in Marketing, Risk, Communications and Security that responsibly connect data on people, devices and locations, continuously corroborated through billions of transactions. Neustar serves more than 8,000 clients worldwide, including 60 of the Fortune 100. Learn how your company can benefit from the power of trusted connections here: https://www.home.neustar.
# # #
Hotwire for Neustar
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-198.3.2021 18:53:00 EET | Press release
Tanner Pharma Group (Tanner) today announced expansion of the LEUKINE Access Program (LeAP) as a channel for distribution of LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the US FDA in 1991 and now manufactured by Partner Therapeutics (PTx), is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that stimulates the immune system and has been used in leukemia patients to reduce the risk of infection. PTx recently announced that a clinical trial of Leukine® conducted in Belgium of hospitalized COVID-19 patients suffering from acute hypoxic respiratory failure requiring supplemental oxygen met the primary endpoint of significant improvement in lung function. Improvement in oxygenation of at least 33% or more from baseline was seen in 54% of patients on the LEUKINE® plus standard-of-care (SOC) arm versus 26% of patients on SOC (p=.0147). Tanner provides a regulatory-compliant pathway to make LEUKINE® available in international markets. If a pat
H.I.G. Capital Expands European WhiteHorse Team with the Addition of Laurent Vaille and Charles Bourgeois8.3.2021 18:30:00 EET | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with over €35 billion of equity capital under management, is pleased to announce the expansion of its European WhiteHorse team with the addition of Laurent Vaille and Charles Bourgeois as Principals. Laurent will be based in H.I.G.’s London office, and Charles is based in H.I.G.’s Paris office. Laurent has 13 years of experience in direct lending and corporate finance. He was previously an Executive Director in the Private Debt division of Tikehau Capital in Paris. Prior to that, he worked for Ernst & Young and Deloitte Finance. Charles has 13 years of experience in direct lending and corporate finance. Prior to joining H.I.G., he was an Executive Director in the Private Debt division of Tikehau Capital in Paris. He was previously with GE Capital in the leveraged finance division, after working at SG and LD&A Jupiter. Commenting on the hire, Pascal Meysson, Head of H.I.G. WhiteHorse Europe, said, “Hiring profe
PerkinElmer Adds HPLC Columns to Consumables Portfolio8.3.2021 18:22:00 EET | Press release
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added state-of-the-art columns and chemistries to its LC consumables portfolio by acquiring ES Industries, based in West Berlin, New Jersey in the U.S. ES Industries is known for its innovative and highly efficient HPLC and supercritical fluid chromatography (SFC) column chemistries. The team has over 40 years of experience delivering columns with superior reliability, scalability, and reproducibility that are used routinely for method development processes, LC/MS analysis, quality control and preparative purification. Building on PerkinElmer’s recently announced LC 300TM HPLC/UHPLC and SimplicityChromTM CDS solution, along with its world class reagents and OneSource® laboratory services, the addition of these column technologies brings customers, such as those in pharmaceuticals/biopharmaceuticals, chemicals, food safety and environmental industries, the convenience of a singl
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 20218.3.2021 17:25:00 EET | Press release
Veristat, a scientific-minded, global clinical research organization (CRO), today congratulated Origin Biosciences for their FDA approval of Nulibry (fosdenopterin) for injection as the first therapy to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A. This rare disease product received FDA approval on Friday, 26 February 2021, during the week when the world celebrated #RareDiseaseDay2021. Veristat’s biostatisticians, programmers, and medical writers collaborated with Origin Biosciences to support the New Drug Application (NDA) for Nulibry. The entire Veristat team is honored to know that the hard work and perseverance of the combined Origin/Veristat team brought new hope for children whose lives are shortened by the devastating disease MoCD Type A. “We thank the entire Veristat team who worked diligently to help us bring this critical therapy to patients with no other FDA-approved treatment options,” said Dr. Liza Squires, Origin Chief Medical
CBS News “Global Thought Leaders” Series Features Echosens: Video Showcases FibroScan® as Medical Gold Standard8.3.2021 17:01:00 EET | Press release
Echosens, a high-technology company offering the FibroScan ® family of products, is pleased to announce that it has been chosen for the “Global Thought Leaders” series broadcast on CBS News. View a short video highlighting the Company’s groundbreaking work in the development of vital medical resources, including FibroScan ® , a noninvasive solution for measuring liver elasticity and fat content of the liver at the point of care. “We’re pleased to be selected by CBS News and proud of the video created at our international headquarters in Paris which captures the essence of Echosens, including interviews with some of our top leaders and a clinician performing a FibroScan ® exam with her patient,” says Dominique Legros, Group CEO, Echosens. “Reliable, accurate and affordable, FibroScan ® is designed to address a growing liver disease epidemic. Nonalcoholic fatty liver disease (NAFLD) affects approximately 25% of the worldwide population and as many as 6% are affected by NASH, which is exp
Infor and C3 AI Form Strategic Partnership to Deliver Scalable Enterprise AI Industry Applications8.3.2021 17:00:00 EET | Press release
C3 AI (NYSE: AI), a leading enterprise AI software provider, and Infor, an ERP technology cloud leader, today announced a wide-ranging strategic alliance designed to jointly expand enterprise-class artificial intelligence (AI) solutions across applicable industries to extend Infor’s native machine learning capabilities. This will allow Infor to explore expansion of its industry offerings into edge scenarios and analyze ways to provide deeper capabilities beyond standard Infor offerings. Infor plans to market, license, and deploy C3 AI prebuilt solutions to Infor customers under the Infor brand and to explore new solutions using the C3 AI® Suite. Infor and C3 AI expect to leverage both companies’ existing digital portfolios to collaborate on new integrated enterprise AI applications that can support specific industry needs. The initial focus will be on predictive maintenance surrounding Internet of Things (IoT) systems with the goal of providing a more proactive and accurate maintenance
NielsenIQ Establishes Independence as a Standalone Company8.3.2021 17:00:00 EET | Press release
Today, NielsenIQ begins its next chapter as an independent company with the closing of its acquisition by Advent International in partnership with incoming Executive Chairman and CEO James “Jim” Peck. As a standalone business, NielsenIQ is better positioned to accelerate its transformation and strengthen its market-leading position. To move forward as a definitive leader in the FMCG industry and usher in a new era of technological advancements and innovation, three new leaders will join NielsenIQ. Mohit Kapoor joins as Chief Technology Officer, overseeing all aspects of technology. Steve Matthesen, a Nielsen veteran, joins as Chief Strategy Officer to help develop and execute the corporate strategy and other key initiatives. Curt Miller joins as Chief Transformation Officer to drive organizational alignment that supports NielsenIQ’s growth strategy. “NielsenIQ has a unique opportunity to become a nimble partner with the flexibility to increase strategic investments and innovation in th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom